Kathleen Anne Boyd (Kathleen A Boyd, Kathleen Boyd)

Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 9

Top Venues

Health technology assessment (Winchester, England)

BMJ (Clinical research ed.)

Human fertility (Cambridge, England)

Trials

University of Glasgow

University Of Glasgow (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Glasgow

United Kingdom

Lecturer :: Health Economics & Health Technology Assessment, Institute of Health & Wellbeing

Education History

University Of Glasgow Sep 1o 2009 - Mar 1o 2012

United Kingdom

PHD :: Institute of Health and Wellbeing

Publications

Rafael Venson, Abha Maheshwari, Scott McGill Nelson, Kathleen Anne Boyd
Setting a tariff for IVF and ICSI treatment: a cost analysis. Human fertility (Cambridge, England) (2023)
Ciaran N Kohli-Lynch, James Lewsey, Kathleen Anne Boyd, Dustin D French, Neil Jordan, Andrew E Moran, Naveed Sattar, David Preiss, Andrew H Briggs
Beyond 10-Year Risk: A Cost-Effectiveness Analysis of Statins for the Primary Prevention of Cardiovascular Disease. Circulation 145 (17) (2022)
David Michael Tappin, Lesley Sinclair, Frank Kee, Margaret McFadden, Lyn Robinson-Smith, Alex Mitchell, Ada Keding, Judith Watson, Sinead Watson, Alison Dick, David Torgerson, Catherine Hewitt, Jennifer McKell, Pat Hoddinott, Fiona M Harris, Kathleen Anne Boyd, Nicola McMeekin, Michael Ussher, Linda Bauld
Effect of financial voucher incentives provided with UK stop smoking services on the cessation of smoking in pregnant women (CPIT III): pragmatic, multicentre, single blinded, phase 3, randomised controlled trial. BMJ (Clinical research ed.) 379 (2022)
Sarah Jane Stock, Margaret Horne, Merel Bruijn, Helen K White, Kathleen Anne Boyd, Robert Heggie, Lisa Wotherspoon, Lorna Aucott, Rachel Katie Morris, Jon Dorling, Lesley Jackson, Manju Chandiramani, Anna Louise David, Asma Khalil, Andrew H Shennan, Gert-Jan van Baaren, Victoria Hodgetts Morton, Tina Lavender, Ewoud Schuit, Susan Harper-Clarke, Ben-Willem J Mol, Richard D Riley, Jane E Norman, John Dt Norrie
Development and validation of a risk prediction model of preterm birth for women with preterm labour symptoms (the QUIDS study): A prospective cohort study and individual participant data meta-analysis. PLoS medicine 18 (7) (2021)
Kathryn Skivington, Lynsay Matthews, Sharon Anne Simpson, Peter Craig, Janis Baird, Jane M Blazeby, Kathleen Anne Boyd, Neil Craig, David P French, Emma McIntosh, Mark Petticrew, Joanne Rycroft-Malone, Heather Brown, Laurence Moore
A new framework for developing and evaluating complex interventions: update of Medical Research Council guidance. BMJ (Clinical research ed.) 374 (2021)
Sarah Jane Stock, Margaret Horne, Merel Bruijn, Helen K White, Robert Heggie, Lisa Wotherspoon, Kathleen Anne Boyd, Lorna Aucott, Rachel Katie Morris, Jon Dorling, Lesley Jackson, Manju Chandiramani, Anna Louise David, Asma Khalil, Andrew H Shennan, Gert-Jan van Baaren, Victoria Hodgetts Morton, Tina Lavender, Ewoud Schuit, Susan Harper-Clarke, Ben-Willem J Mol, Richard D Riley, Jane E Norman, John Dt Norrie
A prognostic model, including quantitative fetal fibronectin, to predict preterm labour: the QUIDS meta-analysis and prospective cohort study. Health technology assessment (Winchester, England) 25 (52) (2021)
Kathryn Skivington, Lynsay Matthews, Sharon Anne Simpson, Peter Craig, Janis Baird, Jane M Blazeby, Kathleen Anne Boyd, Neil Craig, David P French, Emma McIntosh, Mark Petticrew, Joanne Rycroft-Malone, Heather Brown, Laurence Moore
Framework for the development and evaluation of complex interventions: gap analysis, workshop and consultation-informed update. Health technology assessment (Winchester, England) 25 (57) (2021)
Catherine R Hanna, Lauren P Gatting, Kathleen Anne Boyd, Kathyrn A Robb, Rob J Jones
Evidencing the impact of cancer trials: insights from the 2014 UK Research Excellence Framework. Trials 21 (1) (2020)
Timothy J Iveson, Kathleen Anne Boyd, Rachel S Kerr, Jose Antonio Robles-Zurita, Mark P Saunders, Andrew H Briggs, Jim Cassidy, Niels Henrik Hollander, Josep Tabernero, Andrew Haydon, Bengt Glimelius, Andrea Harkin, Karen Allan, John McQueen, Sarah Pearson, Ashita Waterston, Louise Medley, Charles Wilson, Richard Ellis, Sharadah Essapen, Amandeep S Dhadda, Mark Harrison, Stephen Falk, Sherif Raouf, Charlotte Rees, Rene K Olesen, David J Propper, John A Bridgewater, Ashraf Azzabi, David Farrugia, Andrew Webb, David Cunningham, Tamas Hickish, Andrew Weaver, Simon Gollins, Harpreet S Wasan, James Paul
3-month versus 6-month adjuvant chemotherapy for patients with high-risk stage II and III colorectal cancer: 3-year follow-up of the SCOT non-inferiority RCT. Health technology assessment (Winchester, England) 23 (64) (2020)

Kathleen Anne Boyd.css-eqlu8i{font-size:small;padding-left:4px;} (Kathleen A Boyd, Kathleen Boyd)

Publication Activity (10 Years)

Top Topics

Top Venues

Kathleen Anne Boyd (Kathleen A Boyd, Kathleen Boyd)